To measure the rate of disease relapse by six months posttransplant in children and young adults with refractory hematologic malignancies who receive a haploidentical stem cell graft processed using the investigational CliniMACS cell sorting device.

17

All

2 Years to 21 Years (Child, Adult)

NCT00143559

HAPREF

August 2005

July 2006

January 2009

September 2, 2005

January 29, 2009

St. Jude Children's Research HospitalMemphis, Tennessee, United States